Day: July 21, 2025

Boston, MA, July 21, 2025 (GLOBE NEWSWIRE) — Vystar® Corporation (OTCQB: VYST) On November 27, 2024, the New York federal district court in the case EMA Financial LLC v. Vystar Corp., 19-cv-1545 (GWG) issued a first of its kind court victory for a micro-cap issuer, Vystar, denying EMA Financial’s $4,226,187 claim for damages as it related to a toxic convertible note issue. While the district court did not grant Vystar’s counterclaim for damages, in addition to dismissing EMA Financial’s complaint the district court awarded Vystar legal fees. Both parties appealed the decision to the United States Court of Appeals for the Second Circuit. EMA Financial sought to have the appellate court reverse the district court’s dismissal of the complaint. Vystar opposed the appeal and further cross-appealed seeking to have the appellate...

LUXEMBOURG, July 21, 2025 (GLOBE NEWSWIRE) — On Thursday, July 24, 2025, Altisource Portfolio Solutions S.A. (“Altisource”) (NASDAQ: ASPS) will report earnings for the second quarter 2025. A press release and presentation will be available on Altisource’s website in the Investor Relations section. Altisource will also host a conference call at 8:30 a.m. EDT on the same day to discuss its second quarter 2025 results. A link to the live audio webcast will be available on Altisource’s website in the Investor Relations section. Those who want to listen to the call should go to the website at least fifteen minutes prior to the call to register, download and install any necessary audio software. A replay of the conference call will be available via the website approximately two hours after the conclusion of the call and will remain available...

SHENZHEN, China, July 21, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, they announced that they have purchased up to $200 million in Bitcoin and cryptocurrency-related securities derivatives. As of July. 21, the cumulative investment income have reached $35.96million. HOLO currently holds $394 million in cash reserves. The company plans to allocate these $394 million reserves toward derivatives and technology development in cutting-edge fields such as Bitcoin-related blockchain, quantum computing, quantum holography, and AI-powered AR.This move marks HOLO’s further exploration and practice in the cryptocurrency sector while also demonstrating its determination and strategic vision for future business expansion. The purchased Bitcoin and its...

Date: 21 July 2025 Release: After closing of Euronext Please open the following link to read the full report including annexes:AttachmentFULL PRESS RELEASE

New building next to Akropolis KlaipėdaVisualThe Klaipėda City Municipality has issued a construction permitting document for a new building to be constructed next to the shopping and entertainment centre Akropolis. A modern 3,500 sqm single-storey building with a separate entrance will be developed at the northern side of the shopping and entertainment centre, near Entrance No. 3. “By investing in shopping and entertainment centres, our first goal is to offer visitors even more choice, ensuring that here every resident of Klaipėda or city guest finds what they are looking for. We believe that the new building will allow us to expand our supply even further, while creating a comfortable and enjoyable shopping environment. We will inform the public about the expected start and progress of the construction via a separate announcement,”...

PRESS RELEASE Courbevoie, France – July 21, 2025 Half-year report on the liquidity contract Under the liquidity contract entrusted by Bureau Veritas to Rothschild Martin Maurel, as at the date of June 30, 2025, the following assets were included in the liquidity account:15,000 Bureau Veritas shares10,510,215 euros in cashIn the period from January 7, 2025 (date of implementation of the liquidity contract between Bureau Veritas and Rothschild Martin Maurel) to June 30, 2025, the following transactions took place:Shares purchased: 3,880,181 shares (6,726 transactions) for a total of 111,320,894 eurosShares sold: 4,001,491 shares (13,631 transactions) for a total of 114,949,282 eurosIt should be noted that: When implementing the liquidity contract on January 7, 2025, the following assets were included in the liquidity account:136,310...

Virtek LaserUp-close projection technology with a Virtek LaserFARO Blink Imaging Laser ScannerConstruction worker scanning with BlinkLAKE MARY, Fla., July 21, 2025 (GLOBE NEWSWIRE) — AMETEK, Inc. today announced that it has completed its acquisition of FARO Technologies, a global leader in 3D measurement and imaging solutions. FARO will join Creaform and Virtek as part of AMETEK’s Ultra Precision Technologies Division. Together, FARO, Creaform, and Virtek now offer one of the most comprehensive, powerful, and trusted portfolios of portable and automated 3D metrology, laser projection and digital reality solutions available in the industry. This strategic acquisition brings together decades of innovation and expertise to serve a wide range of applications and industries, including:Industrial Manufacturing: Portable...

Stjórn Reita fasteignafélags hf. samþykkti nýja endurkaupaáætlun félagsins þann 1. júlí 2025 sbr. tilkynningu í Kauphöll þann dag. Var henni hrint í framkvæmd þann 2. júlí 2025. Endurkaupaáætlunin er framkvæmd í samræmi við ákvæði hlutafélagalaga nr. 2/1995, 5. gr. reglugerðar Evrópuþingsins og ráðsins (ESB) um markaðssvik nr. 596/2014, sem og framselda reglugerð framkvæmdastjórnarinnar 2016/1052, samanber lög um aðgerðir gegn markaðssvikum nr. 60/2021.Dagsetning Tími Keyptir hlutir Gengi Kaupverð Eigin hlutir eftir viðskipti14/7/25 10:04 70.000 114,00 7.980.000 5.170.00014/7/25 10:08 70.000 114,00 7.980.000 5.240.00014/7/25 15:08 100.000 114,00 11.400.000 5.340.00015/7/25 14:46 100.000 114,00 11.400.000 5.440.00016/7/25 13:47 100.000 114,00 11.400.000 5.540.00016/7/25 15:04 100.000 114,00 11.400.000 5.640.00017/7/25 11:45 100.000 114,00 11.400.000 5.740.00017/7/25 15:14 100.000 114,00 11.400.000 5.840.000           Samtals   740.000   84.360.000 5.840.000Reitir...

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) — Further to our announcement filed on Form 6-K on November 20, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood-derived, cell-based allogeneic therapies for the affordable treatment of blood and solid cancers, is pleased to announce the successful completion of dose level 1 for its first-in-human Phase I dose-escalation clinical trial (NCT05302037) (“ANGELICA Trial”) for four late stage cancer patients and is scheduled to start dose level 2 of the ANGELICA Trial in third quarter of 2025. The ANGELICA Trial evaluates the safety and tolerability of allogeneic NKG2DL-targeting chimeric antigen receptor-grafted (CAR) gamma delta...